Bayesian Capital Management, LP

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1632551 Brooklyn, NY

Position in IOVA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$63,648

+$21,879 QoQ

Shares Held

15,300

0.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#199

of 287 holders

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bayesian Capital Management, LP holds $2,677,814 across 10 Biotechnology names. IOVA ranks #8 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,700	$607,734
2	APGE	Apogee Therapeutics, Inc.	4,300	$570,739
3	REGN	Regeneron Pharmaceuticals, Inc.	808	$503,820
4	GMAB	Genmab A/S	10,369	$284,836
5	ARWR	Arrowhead Pharmaceuticals, Inc.	3,300	$268,983
6	SMMT	Summit Therapeutics Inc.	17,200	$250,604
7	MDXG	Mimedx Group, Inc.	18,400	$70,840
8	IOVA	Iovance Biotherapeutics, Inc. This page	15,300	$63,648

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$63,648	15,300	0.0%	Shares	Sole	2026-08-14
2025-12-31	$41,769	15,300	-74.2%	Shares	Sole	2026-02-17
2025-03-31	$197,538	59,321	-67.8%	Shares	Sole	2025-05-15
2024-09-30	$1,731,516	184,400	+290.7%	Shares	Sole	2024-11-14
2024-06-30	$378,544	47,200	-68.9%	Shares	Sole	2024-08-14
2024-03-31	$2,248,194	151,700	+328.5%	Shares	Sole	2024-05-15
2023-12-31	$287,802	35,400	+145.8%	Shares	Sole	2024-02-14
2023-09-30	$65,520	14,400	-82.7%	Shares	Sole	2023-11-14
2023-06-30	$587,276	83,420	-22.6%	Shares	Sole	2023-08-14
2022-06-30	$1,189,913	107,782	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.